Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT05727683. IPD Sharing: NO. Countries: 1. Publications: 0.
PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy
ClinicalTrials.gov study NCT04745949. IPD Sharing: Not stated. Countries: 1. Publications: 0.
FT819 in Subjects With B-cell Malignancies
ClinicalTrials.gov study NCT04629729. IPD Sharing: NO. Countries: 1. Publications: 0.
Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01955499. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation
ClinicalTrials.gov study NCT00003963. IPD Sharing: Not stated. Countries: 1. Publications: 0.
B-Cell Targeted Carfilzomib Desensitization
ClinicalTrials.gov study NCT02442648. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cell Therapy with Anti-CD19 CAR-NK Cells in Patients with Relapsed or Resistant B-ALL
ClinicalTrials.gov study NCT06631040. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Hypofractionation Radiotherapy in Combination with Glofitamab in Relapsed/refractory Diffuse B-cell Lymphoma with Baseline High Tumor Burden
ClinicalTrials.gov study NCT06867536. IPD Sharing: NO. Countries: 0. Publications: 0.
High Dose, Absorbed Dose Adjusted 90Y-ibritumomab With Peripheral Blood Stem Cells (PBSC) Support in B-cell Lymphoma
ClinicalTrials.gov study NCT00761384. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B-ALL
ClinicalTrials.gov study NCT07008885. IPD Sharing: Not stated. Countries: 1. Publications: 0.
C752 for Refractory/Relapsed B Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06210243. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
ClinicalTrials.gov study NCT05458297. IPD Sharing: YES. Countries: 21. Publications: 0.
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Lymphoma
ClinicalTrials.gov study NCT06879470. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT05480501. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses
ClinicalTrials.gov study NCT02012309. IPD Sharing: NO. Countries: 1. Publications: 0.
FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00079443. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01944943. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL
ClinicalTrials.gov study NCT06080191. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Y
ClinicalTrials.gov study NCT05621291. IPD Sharing: YES. Countries: 1. Publications: 0.
Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
ClinicalTrials.gov study NCT06350318. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.